A股異動 | 英飛特(300582.SZ)直線拉昇漲超3% 增資入股奧思偉爾 佈局新能源汽車領域
格隆匯7月27日丨英飛特(300582.SZ)午後直線拉昇,現報14.34元,漲3.46%,暫成交3238萬元,最新總市值28億元。英飛特今日午間發公告稱,為促進公司在新能源汽車電驅、電控系統領域的產業發展,公司擬使用自有資金1500萬元對奧思偉爾進行增資。英飛特表示,本次對外投資是公司佈局新能源汽車行業的重要舉措。同時,通過本次投資,公司將與標的公司建立更緊密的業務協同關係,拓展公司在新能源汽車電池系統的充電機、DCDC、換電站充電機和均衡機等產品的市場份額,提高公司的盈利能力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.